Jui-yi W. Chen

Tainan, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 85 publications

Early Sodium-Glucose Cotransporter-2 Inhibitor Use After Acute Kidney Injury in Type 2 Diabetes.

Early Sodium-Glucose Cotransporter-2 Inhibitor Use After Acute Kidney Injury in Type 2 Diabetes.

Journal: JAMA network open

Published: August 27, 2026

Sepsis and Infectious Outcomes for GLP-r Agonists in CKD plus Type 2 Diabetes.

Sepsis and Infectious Outcomes for GLP-r Agonists in CKD plus Type 2 Diabetes.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: August 07, 2026

Severe Pregnancy-Associated Acute Kidney Injury and Maternal Vulnerability.

Severe Pregnancy-Associated Acute Kidney Injury and Maternal Vulnerability.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: July 06, 2026

Recombinant zoster vaccine and risk of kidney failure, cardiovascular, and mortality in patients with chronic kidney disease.

Recombinant zoster vaccine and risk of kidney failure, cardiovascular, and mortality in patients with chronic kidney disease.

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: April 23, 2026

Cardiovascular and renal outcomes of combined SGLT2 inhibitors and GLP-1 receptor agonists versus monotherapy in patients with type 2 diabetes mellitus: a network meta-analysis.

Cardiovascular and renal outcomes of combined SGLT2 inhibitors and GLP-1 receptor agonists versus monotherapy in patients with type 2 diabetes mellitus: a network meta-analysis.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Published: March 26, 2026

Safety and clinical impact of SGLT2 inhibitor in patients undergoing peritoneal dialysis: a target-trial emulation study.

Safety and clinical impact of SGLT2 inhibitor in patients undergoing peritoneal dialysis: a target-trial emulation study.

Journal: Clinical kidney journal

Published: February 26, 2026

Impact of sodium-glucose cotransporter-2 inhibitors on clinical outcomes in patients with type 1 diabetes after dialysis-requiring acute kidney injury: a real-world cohort study.

Impact of sodium-glucose cotransporter-2 inhibitors on clinical outcomes in patients with type 1 diabetes after dialysis-requiring acute kidney injury: a real-world cohort study.

Journal: Diabetes research and clinical practice

Published: February 24, 2026

Amyloidosis in Carpal Tunnel Syndrome and 1-Year Cardiovascular and Renal Outcomes: A Propensity Score-Matched Cohort Study.

Amyloidosis in Carpal Tunnel Syndrome and 1-Year Cardiovascular and Renal Outcomes: A Propensity Score-Matched Cohort Study.

Journal: Journal of the American Heart Association

Published: February 12, 2026

Efficacy of combined sodium-glucose cotransporter 2 inhibitors and finerenone in chronic kidney disease: a systematic review and meta-analysis.

Efficacy of combined sodium-glucose cotransporter 2 inhibitors and finerenone in chronic kidney disease: a systematic review and meta-analysis.

Journal: Frontiers in pharmacology

Published: February 04, 2026

Comparative effectiveness of SGLT-2 inhibitors and GLP-1 receptor agonists on the risk of incident dementia after acute kidney injury: a target-trial emulation.

Comparative effectiveness of SGLT-2 inhibitors and GLP-1 receptor agonists on the risk of incident dementia after acute kidney injury: a target-trial emulation.

Journal: GeroScience

Published: January 26, 2026

Influenza vaccination after advanced acute kidney injury: effects on mortality, cardiovascular events, and pneumonia-a target trial emulation.

Influenza vaccination after advanced acute kidney injury: effects on mortality, cardiovascular events, and pneumonia-a target trial emulation.

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: December 21, 2025

Clinical outcomes associated with ACE inhibitors and ARBs use in adults older than 85 years who recovered from dialysis-requiring acute kidney injury.

Clinical outcomes associated with ACE inhibitors and ARBs use in adults older than 85 years who recovered from dialysis-requiring acute kidney injury.

Journal: British journal of clinical pharmacology

Published: August 06, 2025

Showing 1-12 of 85

Last Updated: 09/26/2026